Gilead Sciences, Inc.GILDNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank69
3Y CAGR+78.7%
5Y CAGR+5.1%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
+78.7%/yr
Quarterly compound
5Y CAGR
+5.1%/yr
Recent acceleration
Percentile
P69
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.50% |
| Q3 2025 | 9.70% |
| Q2 2025 | 2.77% |
| Q1 2025 | -0.71% |
| Q4 2024 | 4.57% |
| Q3 2024 | 1.06% |
| Q2 2024 | 4.25% |
| Q1 2024 | -23.21% |
| Q4 2023 | 2.28% |
| Q3 2023 | 5.53% |
| Q2 2023 | 0.65% |
| Q1 2023 | -0.96% |
| Q4 2022 | 0.96% |
| Q3 2022 | 4.25% |
| Q2 2022 | 1.43% |
| Q1 2022 | -5.38% |
| Q4 2021 | -1.90% |
| Q3 2021 | 8.85% |
| Q2 2021 | 4.02% |
| Q1 2021 | 3.99% |
| Q4 2020 | 4.29% |
| Q3 2020 | -3.70% |
| Q2 2020 | -17.75% |
| Q1 2020 | -1.77% |
| Q4 2019 | 9.26% |
| Q3 2019 | -8.59% |
| Q2 2019 | 3.47% |
| Q1 2019 | 3.71% |
| Q4 2018 | -5.97% |
| Q3 2018 | 6.02% |
| Q2 2018 | 5.97% |
| Q1 2018 | 0.73% |
| Q4 2017 | -18.88% |
| Q3 2017 | 9.45% |
| Q2 2017 | 10.48% |
| Q1 2017 | 8.69% |
| Q4 2016 | 12.05% |
| Q3 2016 | 8.79% |
| Q2 2016 | 19.08% |
| Q1 2016 | -23.84% |